Results 201 to 210 of about 326,995 (379)

Neurotoxicity and management of primary and secondary central nervous system lymphoma after adoptive immunotherapy with CD19-directed chimeric antigen receptor T-cells. [PDF]

open access: yesNeuro Oncol, 2023
Karschnia P   +26 more
europepmc   +1 more source

PRMT3‐Mediated H4R3me2a Promotes Primary Age‐Related Tauopathy by Driving Tau Hyperphosphorylation in Neuron

open access: yesAdvanced Science, EarlyView.
This study identifies PRMT3‐mediated H4R3me2a as a critical driver of tau hyperphosphorylation in primary age‐related tauopathy. Mechanistic insights reveal that the PRMT3/H4R3me2a/miR‐448 axis suppresses IGF1R expression via epigenetic regulation, further dysregulating the PI3K/AKT/GSK3β pathway.
Haotian Liu   +9 more
wiley   +1 more source

mRNAs encoding IL-12 and a decoy-resistant variant of IL-18 synergize to engineer T cells for efficacious intratumoral adoptive immunotherapy. [PDF]

open access: yesCell Rep Med, 2023
Olivera I   +18 more
europepmc   +1 more source

Adjuvant adoptive immunotherapy with tumour-infiltrating lymphocytes and modulated doses of interleukin-2 in 22 patients with melanoma, colorectal and renal cancer, after radical metastasectomy, and in 12 advanced patients

open access: green, 1998
Ruggero Ridolfi   +9 more
openalex   +1 more source

Sequential modulation of growth factors: A novel strategy for adoptive immunotherapy of acute myeloid leukemia [PDF]

open access: hybrid, 2002
Rui‐kun Zhong   +6 more
openalex   +1 more source

A Needle‐Like H2S‐Releasing and H2O2 Self‐Replenishing Nanoplatform for Enhanced Chemodynamic Tumor Immunotherapy

open access: yesAdvanced Science, EarlyView.
The PTA‐SnS2@GOx cascade nanosystem presents a smart paradigm for cancer theranostics, integrating self‐supplied H2S/H2O2‐augmented chemodynamic therapy (CDT) with sensitized immunotherapy. Its needle‐like SnS2 shell enhances tumor‐specific uptake, ensuring biosafety.
Xiaoxiao Sun   +3 more
wiley   +1 more source

Nanoparticle-based modulation of CD4+ T cell effector and helper functions enhances adoptive immunotherapy. [PDF]

open access: yesNat Commun, 2022
Isser A   +17 more
europepmc   +1 more source

Novel immunotherapies for immune-mediated haemolytic anaemia in dogs and people [PDF]

open access: yes, 2015
Aerts   +111 more
core   +1 more source

Tissue distribution of target antigen has a decisive influence on the outcome of adoptive cancer immunotherapy [PDF]

open access: bronze, 2002
Marie‐Christine Meunier   +3 more
openalex   +1 more source

EGFR‐TKIs Induced DPP4 Drives Metabolic Reprogramming of Persister Cells in Lung Cancer

open access: yesAdvanced Science, EarlyView.
Drug‐tolerant persister (DTP) cells emerge early during EGFR‐TKI treatment, preceding the development of acquired resistance. Elevated DPP4 in DTP cells drives metabolic reprogramming and antioxidant adaptation, promoting cell survival under drug pressure.
Yuanzhou Zhang   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy